HBM Healthcare Investments (Cayman) Ltd.

Overview

• HeadquartersWest Bay, Cayman Islands²
• Incorporated inCayman Islands³
• Business addressGovernors Square, 23 Lime Tree Bay Ave.,, Po Box 30852, Grand Cayman, E9 Ky1-1204³
• Legal formcompany limited by shares²
• LEI5493000BQZ1FBRJL5B84²
• StatusActive²
• LEI statusIssued and current²
• Registered addressGovernors Square, KY1-9000 West Bay, Cayman Islands²
• Registered withGeneral Registry, CR-110122²

See how the biggest companies compare on our leaderboards

Corporate structure

HBM Healthcare Investments (Cayman) Ltd. is part of a group headed by HBM Healthcare Investments. 19 entities, 5 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (16 companies). Each entity in the chart links to its source.

Subsidiaries and ownership

Parent company (GLEIF)

• HBM Healthcare Investments 100%²

Subsidiaries (GLEIF)

• HBM Private Equity India 100%⁴

Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.

Former names

• HBM BIOVENTURES CAYMAN LTDMay 13, 2003 to Mar 21, 2013³

Timeline

1. Jul 13, 2012Parent Directly consolidated by HBM Healthcare Investments²
2. Jul 13, 2012Founded HBM Healthcare Investments (Cayman) Ltd. is founded²

Stakes it holds

HBM Healthcare Investments (Cayman) Ltd. has told the SEC it owns more than 5% of 16 companies, latest first (Schedules 13D and 13G).

• Vicore Pharma Holding ABSCHEDULE 13G Oct 13, 2026⁵
• Chemomab Therapeutics Ltd.SCHEDULE 13D/A Jul 16, 2026 to Sep 9, 2026⁶
• ALX ONCOLOGY HOLDINGS INCSCHEDULE 13G/A Dec 27, 2024 to May 15, 2026⁷
• IO Biotech, Inc.SCHEDULE 13G/A Feb 11, 2022 to Apr 6, 2026⁸
• Upstream Bio, Inc.SCHEDULE 13G/A Feb 13, 2025 to Nov 14, 2025⁹
• Y-mAbs Therapeutics, Inc.SCHEDULE 13G/A Feb 7, 2022 to Nov 14, 2025¹⁰
• ArriVent BioPharma, Inc.SCHEDULE 13G Oct 15, 2025¹¹
• Immuneering CorpSCHEDULE 13G Oct 3, 2025¹²
• Benitec Biopharma LtdSCHEDULE 13G/A Apr 29, 2024 to Feb 13, 2025¹³
• Mineralys Therapeutics, Inc.SC 13G/A Feb 13, 2024 to Nov 13, 2024¹⁴
• Alimera SciencesSC 13G/A Feb 13, 2024¹⁵
• Longboard Pharmaceuticals, Inc.SC 13G/A Feb 14, 2023 to Feb 13, 2024¹⁶
• Ambrx Biopharma Cayman, Inc.SC 13G/A Feb 11, 2022 to Feb 14, 2023¹⁷
• Harmony Biosciences Holdings, Inc.SC 13G/A Feb 11, 2022 to Feb 14, 2023¹⁸
• BioAtlaSC 13G/A Feb 11, 2022¹⁹
• Damora Therapeutics, Inc.SC 13G/A Feb 11, 2022²⁰

SEC filer profile

How HBM Healthcare Investments (Cayman) Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARHBM Healthcare Investments (Cayman) Ltd.¹
• CIK0001232258
• Incorporated inCayman Islands¹
• Fiscal year endsMarch 31¹
• Business addressGovernors Square, 23 Lime Tree Bay Ave.,, Po Box 30852, Grand Cayman, E9 KY1-1204¹
• Phone345-946-8002¹
• On EDGAR sinceMay 13, 2003¹
• Filings183 in all: 4 (59), SC 13G/A (47), SC 13G (36), 3 (12), SC 13D/A (9), SCHEDULE 13G/A (7), SC 13D (5), SCHEDULE 13G (5)¹
  All 11 form types

  4/A (1), SCHEDULE 13D (1), SCHEDULE 13D/A (1)